SCYNEXIS, Inc. Proceeds from Divestiture of Businesses
SCYNEXIS, Inc. (SCYX) reported Proceeds from Divestiture of Businesses of $500.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2016-11-07
- 2016-09-30: Proceeds from Divestiture of Businesses 9 month $500.00K.
- 2015-09-30: Proceeds from Divestiture of Businesses 9 month $2.55M.
| Period end | Proceeds from Divestiture of Businesses 9 month |
|---|---|
| 2016-09-30 | $500.00K 10-Q · filed 2016-11-07 |
| 2015-09-30 | $2.55M 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |